Method of treating non-streptococcal bacterial infections
AssigneeImmtech International Inc.
InventorLawrence A. Potempa
Life of this patent
Estimating the term…
Abstract
A method of treating non-Streptococcal bacterial infections in a mammal comprising administering to the mammal an effective amount of modified C-reactive protein (CRP) in a pharmaceutically-acceptable carrier. Modified-CRP has been found to be particularly effective in treating gram-negative bacterial infections and endotoxic shock.
Claims12
A method of treating a bacterial infection in a mammal caused by a bacterium other than a Streptococcus sp., the method comprising administering to the mammal an effective amount of modified-C-reactive protein (modified-CRP) in a pharmaceutically-acceptable carrier.
A method of treating a gram-negative bacterial infection in a mammal comprising administering to the mammal an effective amount of modified-C-reactive protein (modified-CRP) in a pharmaceutically-acceptable carrier.
A method of treating endotoxic shock in a mammal comprising administering to the mammal an effective amount of modified-C-reactive protein (modified-CRP) in a pharmaceutically-acceptable carrier.
Dependencies are inferred from the claim text.